The purpose of this study was to calculate the cost-effectiveness of MRI screening for breast cancer in BRCA1/2 mutation carriers in a Canadian setting. Methods: We constructed a Markov model of annual MRI and mammography screening for BRCA1/2 carriers, using local data and published values. ...
Purpose The aim of this study was to estimate the cost effectiveness of breast cancer screening with contrast-enhanced magnetic resonance imaging (MRI), with and without adjunctive x-ray mammography (XM), compared with XM alone in high-risk women. Materials and Methods A model was developed to...
Screening mammography performed annually on all women beginning at age 40 years has reduced breast cancer deaths by 30% to 50%. The cost per year of life saved is well within the range for other commonly accepted medical interventions. Various studies have estimated that reduction in treatment c...
Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk Magnetic resonance imaging (MRI) is recommended for women at high risk for breast cancer. We evaluated the cost-effectiveness of alternative screening stra... CH Ahern,YCT Shih,W Don...
As a result, the disease stage in those patients screened by MRI is lower than in the patients screened by a different method. In well-defined groups MRI of the breasts may be an important additional screening tool in women at increased risk of breast cancer. 展开 ...
Reports that combined magnetic resonance imaging (MRI) and mammography is the best method of detecting breast cancer in patients with high genetic risk. Study published online by "The Lancet"; Indication that MRI was nearly twice as sensitive...
As part of our MBCC coverage we discuss MRI screening for breast cancer in patients who carry a BRCA mutation or have a first-degree relative who is a BRCA carrier.
Will we still be using mammography for breast cancer screening one fourth of the way through this century? That was the question posed in one session at ECR 2011, and speaker Christine Kuhl said she greatly fears that we actually may. "Why not use what we already have for screening?" she...
Not cost-effective: An MRI is an expensive examination that is not affordable for most people, unlike a mammogram. Overtreatment: Breast cancer may occasionally be overtreated as a result of MRI. If an MRI reveals that there is more cancer in the breast than predicted, the medical team may...
The Future of Breast Cancer Screening Given the clear benefits of other means of more accurate screening, why aren’t they the standard for all women? The answer lies in the complex interplay of cost, insurance and accessibility. However, there is hope on the horizon. Advances in technology ...